Intelligence Platform

Patents

Browse 255 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12421316

Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12416008

Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity usin

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12409224

Compositions and methods for the treatment of VEN/AZA resistant acute myeloid leukemia

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12409228

Hydrogel drug delivery systems for the treatment of pediatric growth plate injuries

granted patent

US 12396994

Compositions for improving physiological function with age

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12396991

Biomarkers for the diagnosis and treatment of fibrotic lung disease

granted patent

US 12384829

Pocket engineering of HLA alleles for treating autoimmunity

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12364765

Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12350250

Aggrelytes for treating ocular conditions

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12331078

Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast su

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12303602

Compositions, methods and uses for thermally stable multi-targeted antigens

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12291502

Topoisomerase II-alpha inhibitors and methods of treating cancer using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12285627

Fabrication and irradiation of a radioactive isotope skin patch

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12285357

Intraocular drug delivery systems and methods of use

granted patent

US 12226450

Peptides and methods for treating disease

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12220415

WEE1 kinase inhibitors and methods of treating cancer using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12215060

Performance of technical ceramics

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12194082

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12186384

Compositions and methods for making and using thermostable immunogenic formulations with i

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12162912

Proteins for blocking neurotransmitter release

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12109224

USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in m

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12097291

Thermostable vaccine compositions and methods of preparing same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12084468

Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramid

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12054607

Tough, healable composites displaying stress relaxation at the resin-filler interface

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted